Hepatitis C Virus
Genelabs Technologies, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2007
Published in Hepatitis Weekly, November 26th, 2007
Genelabs Technologies, Inc. (NASDAQ:GNLB) reported revenues of $4.6 million and a net loss of $0.1 million, or $0.00 per share, for the third quarter of 2007. This compares to revenues of $3.6 million and a net loss of $0.6 million, or $0.03 per share, for the third quarter of 2006. Revenues for the first nine months of 2007 were $12.9 million, and the net loss was $1.0 million, or $0.03 per share, compared to revenues of $7.6 million and a net loss of $8.3 million, or $0.42 per share, for the first nine months of 2006.
Genelabs had cash and cash equivalents of $20.2 million at September 30, 2007. Subsequent to September 30, 2007 our cash and cash equivalents balance...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2007-11-26)
More Articles from Hepatitis Weekly
- Hepatitis C Virus
Interferon does not slow or stop hepatitis C from worsening, study finds - Hepatitis A Virus
New findings from L.M. Villar and co-authors describe advances in hepatitis A virus - Hepatitis B Virus
Data from T. Vassiliadis et al provide new insights into hepatitis B virus - Hepatitis B Virus
Investigators at Chinese University of Hong Kong target hepatitis B virus - Hepatitis B Virus
Scientists at Zhengzhou University report research in hepatitis B virus - Hepatitis B Virus
Study results from University of Washington provide new insights into hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
